Ulrike Garske‐Román

Individualized Dosimetry of Kidney and Bone Marrow in Patients Undergoing ¹⁷⁷Lu-DOTA-Octreotate Treatment

Mattias Sandström, Ulrike Garske‐Román, Silvia Johansson et al. · Journal of Nuclear Medicine · 2012 · 287 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the ¹¹¹In-ABY-025 Affibody Molecule

Jens Sørensen, Dan Sandberg, Mattias Sandström et al. · Journal of Nuclear Medicine · 2014 · 260 citations · Full text

Medicine, Oncology, Pharmacokinetics +17

Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

Ulrike Garske‐Román, Mattias Sandström, Katarzyna Fröss Baron et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 249 citations · Full text

Medicine, Nuclear Medicine, Oncology +16

Dose Response of Pancreatic Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy Using ¹⁷⁷Lu-DOTATATE

Ezgi Ilan, Mattias Sandström, Cecilia Wassberg et al. · Journal of Nuclear Medicine · 2015 · 221 citations · Full text

Medicine, Nuclear Medicine, Oncology +16

Quantitative and Qualitative Intrapatient Comparison of ⁶⁸Ga-DOTATOC and ⁶⁸Ga-DOTATATE: Net Uptake Rate for Accurate Quantification

Irina Velikyan, Anders Sundin, Jens Christian Hedemann Sørensen et al. · Journal of Nuclear Medicine · 2013 · 180 citations · Full text

Medicine, Nuclear Medicine, Oncology +17